


BlueSphere Bio Revenue
Biotechnology Research • Pittsburgh, Pennsylvania, United States • 21-50 Employees
BlueSphere Bio revenue & valuation
| Annual revenue | $3,593,310 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $11,500,000 |
| Total funding | No funding |
Key Contacts at BlueSphere Bio
Keir J. Loiacono
Chief Executive Officer
James Akin
Executive Director Business Development
Alun Carter
Executive Director Of Immunology
Paras Jain
Director, Quality Assurance & Compliance
Adam Parks
Director, Protein Science
Brooke Helfer
Senior Director Of Product Development
Jennifer Roy
Associate Director Of Lab Operations
Michele Jenkins
Sr Director Clinical Operations
Warren Shlomchik
Co-Founder
Paola Sette
Associate Director
Company overview
| Headquarters | 350 Technology Drive, Suite 520, Pittsburgh, PA 15219, US |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Oncology, Immunotherapies, Autoimmune Diseases, T-Cell Therapies, T-Cell Treatments |
| Founded | 2018 |
| Employees | 21-50 |
| Socials |
BlueSphere Bio Email Formats
BlueSphere Bio uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@bluespherebio.com), used 59.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@bluespherebio.com | 64.9% |
{first name}{last name} | johndoe@bluespherebio.com | 29.7% |
{last name}{last name} | doedoe@bluespherebio.com | 5.4% |
About BlueSphere Bio
BlueSphere Bio was founded to unlock the potential of personalized T cell therapy for the treatment of cancer by harnessing the unique specificity of each patient’s own T cells for the particular molecular fingerprint of each patient’s own cancer through our novel TCXpress technology. Our proprietary TCXpress platform is an elegant, rapid approach that exploits the patient’s own immune defenses to attack their cancer specifically, and is designed to leave normal tissues untouched, thereby reducing harmful side effects. The platform and implementation allows us to deliver rapid, personalized T cell treatments for a variety of cancer indications.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
BlueSphere Bio has 23 employees across 10 departments.
Departments
Number of employees
Funding Data
BlueSphere Bio has never raised funding before.
BlueSphere Bio Tech Stack
Discover the technologies and tools that power BlueSphere Bio's digital infrastructure, from frameworks to analytics platforms.
WordPress themes
JavaScript libraries
Page builders
JavaScript libraries
JavaScript libraries
Webmail
Programming languages
Security
Blogs
Analytics
Tag managers
Frequently asked questions
4.8
40,000 users



